Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

A Common Transcriptional Signature in Glioblastoma Multiforme Recurrence and Brain Regeneration

EF 2022-23

Résumé
Glioblastoma Multiforme (GBM) is a highly lethal and recurrent brain cancer comprised of many different types of cells. Interestingly, GBM recurrence mostly happens within the site of radiation therapy. Researchers suspect that GBM recurrence is due to a type of cell in the tumor called a cancer stem cell. Cancer stem cells can give rise to many different cell types and are capable of generating an entire tumor on their own. A recent publication has identified the gene F3 as a marker for these cancer stem cells in GBM, also known as glioma stem cells (GSCs). There is also evidence suggesting that GBM occurs in response to injury. I suspect that there is a set of genes involved in GBM recurrence that could be applied to enhance brain regeneration. To identify other marker genes for GSCs, I would first perform genomic analysis on patient tumor cells to find genes that are expressed similarly as F3. Secondly, I would genetically engineer GBM cells to overexpress GSC marker genes and inject them into cerebral organoids. Cerebral organoids (COs) are ‘mini-brains’ made from human embryonic stem cells (hESCs) and serve as a model for patient brains. I would then irradiate the COs to mimic radiotherapy and assess the resulting tumor recurrence to confirm the involvement of the putative marker genes in GBM recurrence. Finally, to determine the role of marker genes in brain regeneration, hESCs engineered in a similar manner as the GBM cells could be used to generate COs. They would then be irradiated to induce damage and their injury and regenerative response would be compared to irradiated COs made from normal hESCs. If my results support my theory, the marker genes could serve as therapeutic targets and allow for the development of new treatments for both GBM and brain damage.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485993
Name
Lau Tsz Yin C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Common Transcriptional Signature in Glioblastoma Multiforme Recurrence and Brain Regeneration
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Cancer; Brain Tumor Stem Cells; Cancer; Cancer Stem Cells; Cerebral Organoids; Genomic Analysis; Glioblastoma; Neuro-Oncology; Regeneration; Single-Cell Rna Sequencing
Abstract
Glioblastoma Multiforme (GBM) is a highly lethal and recurrent brain cancer comprised of many different types of cells. Interestingly, GBM recurrence mostly happens within the site of radiation therapy. Researchers suspect that GBM recurrence is due to a type of cell in the tumor called a cancer stem cell. Cancer stem cells can give rise to many different cell types and are capable of generating an entire tumor on their own. A recent publication has identified the gene F3 as a marker for these cancer stem cells in GBM, also known as glioma stem cells (GSCs). There is also evidence suggesting that GBM occurs in response to injury. I suspect that there is a set of genes involved in GBM recurrence that could be applied to enhance brain regeneration. To identify other marker genes for GSCs, I would first perform genomic analysis on patient tumor cells to find genes that are expressed similarly as F3. Secondly, I would genetically engineer GBM cells to overexpress GSC marker genes and inject them into cerebral organoids. Cerebral organoids (COs) are ‘mini-brains’ made from human embryonic stem cells (hESCs) and serve as a model for patient brains. I would then irradiate the COs to mimic radiotherapy and assess the resulting tumor recurrence to confirm the involvement of the putative marker genes in GBM recurrence. Finally, to determine the role of marker genes in brain regeneration, hESCs engineered in a similar manner as the GBM cells could be used to generate COs. They would then be irradiated to induce damage and their injury and regenerative response would be compared to irradiated COs made from normal hESCs. If my results support my theory, the marker genes could serve as therapeutic targets and allow for the development of new treatments for both GBM and brain damage.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lau, Tsz Yin C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~